Segal Paul 4
4 · Alphatec Holdings, Inc. · Filed Jan 26, 2023
Insider Transaction Report
Form 4
L-5 Healthcare Partners, LLC
10% OwnerOther
Transactions
- Exercise/Conversion
Common Stock
2023-01-25$3.50/sh+2,000,000$7,000,000→ 11,530,346 total - Tax Payment
Common Stock
2023-01-25$13.14/sh−532,513$6,997,221→ 10,997,833 total - Exercise of In-Money
Warrants to Purchase Common Stock
2023-01-25−2,000,000→ 2,346,032 totalExercise: $3.50From: 2018-05-17Exp: 2023-05-17→ Common Stock (2,000,000 underlying)
Footnotes (4)
- [F1]Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.
- [F2]Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.
- [F3]Represents a "cashless exercise" of outstanding warrants. The reporting person received 1,467,487 shares of Common Stock on cashless exercise of warrants to purchase 2,000,000 shares of Common Stock. The Company withheld 532,513 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on January 24, 2023 of approximately $13.14, pursuant to the terms of the warrant.
- [F4]Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer.